University of Alabama at Birmingham, Birmingham, AL, USA.
J Perinatol. 2022 Oct;42(10):1417-1423. doi: 10.1038/s41372-022-01437-y. Epub 2022 Jul 1.
To determine the impact of neuroprotection interventions bundle on the incidence of severe brain injury or early death (intraventricular hemorrhage grade 3/4 or death by 7 days or ventriculomegaly or cystic periventricular leukomalacia on 1-month head ultrasound, primary composite outcome) in very preterm (27 to ≤ 29 weeks gestational age) infants.
Prospective quality improvement initiative, from April 2017-September 2019, with neuroprotection interventions bundle including cerebral NIRS, TcCO, and HeRO monitoring-based management algorithm, indomethacin prophylaxis, protocolized bicarbonate and inotropes use, noise reduction, and neutral positioning.
There was a decrease in the incidence of the primary composite outcome in the intervention period on unadjusted (N = 11/99, pre-intervention to N = 0/127, intervention period, p < 0.001) and adjusted analysis (adjusted for birthweight and Apgar score <5 at 5 min, aOR = 0.042, 95% CI = 0.003-0.670, p = 0.024).
Neuroprotection interventions bundle was associated with significant decrease in severe brain injury or early death in very preterm infants.
确定神经保护干预措施包对极低出生体重儿(胎龄 27 至≤29 周)严重脑损伤或早期死亡(7 天内脑室出血 3/4 级或死亡、脑室扩大、囊性脑室内白质软化症,1 个月头超声,主要复合结局)发生率的影响。
前瞻性质量改进计划,从 2017 年 4 月至 2019 年 9 月,神经保护干预措施包包括脑近红外光谱(NIRS)、经皮二氧化碳分压(TcCO)和肝脏氧合监测(HeRO)监测的管理算法、吲哚美辛预防、方案化碳酸氢盐和正性肌力药物使用、降低噪音和中性体位。
在未调整分析(干预前 n=11/99,干预期间 n=0/127,p<0.001)和调整分析(调整出生体重和 Apgar 评分<5 分 5 分钟时,调整后的优势比[OR]为 0.042,95%置信区间[CI]为 0.003-0.670,p=0.024)中,干预期间主要复合结局的发生率均降低。
神经保护干预措施包与极低出生体重儿严重脑损伤或早期死亡发生率显著降低有关。